Key Statistics for GSK
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (GBP) (ttm)
|Est. EPS (GBP) (12/2013)
|Est. PEG Ratio
|Market Cap (M GBP)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (GBp)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for GSK
- Net Income (M/GBP)
GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.
More Company Profile & Key Executives for GSK
|Andrew WittyChief Executive Officer||Simon P DingemansChief Financial Officer|
|David RedfernChief Strategy Officer||Moncef SlaouiChairman:R&D & Vaccines|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries